Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 12/31/17
Due: 12/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds | NCT02602184 | Arava Bio Tech Ltd. | user2@example.com | None | 2015-11-30 | 2017-06-30 | 2018-06-30 | - | - | 2025-07-14 |
| Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds | NCT02839226 | Arava Bio Tech Ltd. | user2@example.com | None | 2016-08-31 | 2017-12-31 | 2018-12-31 | - | - | 2025-07-14 |